Medpace Holdings [MEDP] vs Iqvia Holdings [IQV] Detailed Stock Comparison

Medpace Holdings

NASDAQ
Loading...

Iqvia Holdings

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Medpace Holdings wins in 8 metrics, Iqvia Holdings wins in 11 metrics, with 0 ties. Iqvia Holdings appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricMedpace HoldingsIqvia HoldingsBetter
P/E Ratio (TTM)39.5629.90Iqvia Holdings
Price-to-Book Ratio86.576.08Iqvia Holdings
Debt-to-Equity Ratio86.93272.12Medpace Holdings
PEG Ratio3.64-1.35Iqvia Holdings
EV/EBITDA29.7416.66Iqvia Holdings
Profit Margin (TTM)18.74%7.88%Medpace Holdings
Operating Margin (TTM)20.94%13.39%Medpace Holdings
EBITDA Margin (TTM)20.94%13.39%Medpace Holdings
Return on Equity89.39%19.79%Medpace Holdings
Return on Assets (TTM)17.09%5.16%Medpace Holdings
Free Cash Flow (TTM)$572.27M$2.11BIqvia Holdings
1-Year Return52.42%-10.57%Medpace Holdings
Price-to-Sales Ratio (TTM)6.702.24Iqvia Holdings
Enterprise Value$15.06B$48.69BIqvia Holdings
EV/Revenue Ratio6.753.10Iqvia Holdings
Gross Profit Margin (TTM)29.84%32.94%Iqvia Holdings
Revenue per Share (TTM)$74$89Iqvia Holdings
Earnings per Share (Diluted)$13.46$6.91Medpace Holdings
Beta (Stock Volatility)1.411.33Iqvia Holdings
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Medpace Holdings vs Iqvia Holdings Stock Performance Analysis

Loading Price Chart...

Medpace Holdings
Iqvia Holdings
Medpace Holdings Stock Overview | Iqvia Holdings Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medpace Holdings-0.41%5.90%7.76%66.29%82.80%58.42%
Iqvia Holdings-0.78%13.45%9.24%26.20%33.99%5.07%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medpace Holdings52.42%246.47%328.56%1,791.23%1,791.23%1,791.23%
Iqvia Holdings-10.57%18.23%24.59%186.46%383.65%383.65%

News Based Sentiment: Medpace Holdings vs Iqvia Holdings

Medpace Holdings

News based Sentiment: MIXED

Medpace is showing strong financial performance with increased institutional investment and positive guidance, but faces a recent analyst downgrade and a relatively high valuation. The combination of positive and negative developments creates a mixed investment picture for the month.

View Medpace Holdings News Sentiment Analysis

Iqvia Holdings

News based Sentiment: POSITIVE

IQVIA delivered a strong Q2 performance, raised its full-year guidance, and saw increased analyst and institutional confidence. While insider selling is a minor concern, the overall narrative for the month is positive, suggesting continued growth and investment potential.

View Iqvia Holdings News Sentiment Analysis

Performance & Financial Health Analysis: Medpace Holdings vs Iqvia Holdings

MetricMEDPIQV
Market Information
Market Cap i$14.96B$36.03B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i278,9801,417,620
90 Day Avg. Volume i314,9431,292,383
Last Close$530.30$205.02
52 Week Range$250.05 - $547.15$134.65 - $237.34
% from 52W High-3.08%-13.62%
All-Time High$547.15 (Oct 01, 2025)$285.61 (Dec 27, 2021)
% from All-Time High-3.08%-28.22%
Growth Metrics
Quarterly Revenue Growth0.14%0.05%
Quarterly Earnings Growth0.02%-0.27%
Financial Health
Profit Margin (TTM) i0.19%0.08%
Operating Margin (TTM) i0.21%0.13%
Return on Equity (TTM) i0.89%0.20%
Debt to Equity (MRQ) i86.93272.12
Cash & Liquidity
Book Value per Share (MRQ)$6.15$33.99
Cash per Share (MRQ)$1.65$12.87
Operating Cash Flow (TTM) i$614.10M$2.62B
Levered Free Cash Flow (TTM) i$445.14M$2.45B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Medpace Holdings vs Iqvia Holdings

MetricMEDPIQV
Price Ratios
P/E Ratio (TTM) i39.5629.90
Forward P/E i42.6317.12
PEG Ratio i3.64-1.35
Price to Sales (TTM) i6.702.24
Price to Book (MRQ) i86.576.08
Market Capitalization
Market Capitalization i$14.96B$36.03B
Enterprise Value i$15.06B$48.69B
Enterprise Value Metrics
Enterprise to Revenue i6.753.10
Enterprise to EBITDA i29.7416.66
Risk & Other Metrics
Beta i1.411.33
Book Value per Share (MRQ) i$6.15$33.99

Financial Statements Comparison: Medpace Holdings vs Iqvia Holdings

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)MEDPIQV
Revenue/Sales i$558.57M$4.02B
Cost of Goods Sold i$380.22M$2.69B
Gross Profit i$178.35M$1.32B
Research & Development iN/AN/A
Operating Income (EBIT) i$113.52M$538.00M
EBITDA i$120.45M$813.00M
Pre-Tax Income i$118.17M$323.00M
Income Tax i$3.58M$56.00M
Net Income (Profit) i$114.60M$266.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)MEDPIQV
Cash & Equivalents i$441.44M$2.04B
Total Current Assets i$821.44M$6.35B
Total Current Liabilities i$1.12B$7.57B
Long-Term Debt i$126.66M$14.39B
Total Shareholders Equity i$593.61M$5.79B
Retained Earnings i$-269.72M$6.58B
Property, Plant & Equipment i$258.19M$816.00M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)MEDPIQV
Operating Cash Flow i$166.55M$459.00M
Capital Expenditures i$-9.99M$-151.00M
Free Cash Flow i$115.84M$292.00M
Debt Repayment iN/A$-1.74B
Common Stock Repurchase i$-371.90M$-657.00M

Short Interest & Institutional Ownership Analysis

MetricMEDPIQV
Shares Short i2.20M4.68M
Short Ratio i6.813.92
Short % of Float i0.10%0.03%
Average Daily Volume (10 Day) i278,9801,417,620
Average Daily Volume (90 Day) i314,9431,292,383
Shares Outstanding i30.63M176.10M
Float Shares i22.25M161.46M
% Held by Insiders i0.21%0.01%
% Held by Institutions i0.97%1.02%

Dividend Analysis & Yield Comparison: Medpace Holdings vs Iqvia Holdings

MetricMEDPIQV
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A